DAPK1 and Alzheimer disease: Previous research by our group found that DAPK1 can phosphorylate these sites and is crucial in cognitive dysfunction in patients with AD or AD mouse models [28,29]; therefore, the protein expression of DAPK1 was significantly elevated in STZ-treated rats.